Abstract
Introduction
Regulatory T cells (Tregs) are critical for the maintenance of immune homeostasis. The most widely recognized and studied subset of Tregs express the transcription factor FoxP3 and can be induced peripherally or develop directly in the thymus [1] [2] [3] ; however, FoxP3 -type 1 regulatory cells (Tr1) are also well-characterized [4, 5] . Another CD4 + T cell subset known to have regulatory/suppressive properties are those lacking FoxP3 while expressing low concentrations ) at the cell surface. These Rb Lo T cells inhibit the induction of wasting disease in SCID mice [6] , type 1 diabetes [7] , a plant antigen-based model of asthma [8] , and the formation of adhesions [9] . In agreement with these reports, we recently found that the polysaccharide antigen PSA from Bacteroides fragilis significantly decreased susceptibility to the development of pulmonary inflammation through activation and expansion of CD4 Tem) [10] [11] [12] . Rb
Lo
Tem cells are known to depend upon IL-10 for their protective efficacy [13, 14] . Consistent with this, we found that the suppressive activity of Rb Lo Tem cells required IL-10 in both humans in vitro [15] and mice in vivo [10, 12] . In an in vivo model in which all cells lacked IL-10, the Rb Lo Tem cells failed to protect the animals from pulmonary inflammation [10] . However, reciprocal adoptive transfer experiments in which activated wild type (WT) or IL-10-deficient (IL-10 In this study, we report the discovery of a mechanism by which Rb
Tem cells communicate with and drive suppressive activity of FoxP3 + Tregs to regulate inflammation. Consistent with our in vivo studies [12] , co-cultured Rb /J) mice, all on the C57BL/6 background, were purchased from the Jackson Laboratory (Bar Harbor, ME). FoxP3-eGFP animals were a kind gift of Drs. Rudensky and Letterio. Mice were fed standard chow (Purina 5010) on a 12-hour light/dark cycle in a specific pathogen free facility. Enrichment and privacy provided in mating cages by 'love shacks' (Bio Serv 53352-400). Mouse studies, and all animal housing at Case Western Reserve University were approved by and performed according to the guidelines established by the Institutional Animal Care and Use Committee of CWRU.
Materials and methods

Mice
Primary splenic T cells
Primary splenocytes were isolated from freshly harvested spleens, and reduced to a single cell suspension by passing them through a sterile 100μM nylon mesh cell strainer (Fisher Scientific, Hampton, NH). For splenic T cell enrichment, single cell suspensions were labeled with anti-Foundation to BC, the National Institutes of Health (F32-AI114109, T32-AI007024) to MJ, and the National Institutes of Health (T32-AI089474) to JJ, JZ, and CA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
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Abbreviations
Pulmonary inflammation and adoptive transfer
HDM model. Mice were challenged with house dust mite antigen (HDM, D. Farinae, GREER, Lenoir, NC) by intranasal delivery of 20μg HDM/dose in PBS on days 0-4 and 7-11 and sacrificed on day 14 [16] . For adoptive transfer, 60,000 Rb Lo Tem cells were harvested by FACS from FoxP3-eGFP reporter mice and i.v. injected on day 6. Animals were anesthetized with 3% isoflurane (Baxter) with an anesthesia system (VetEquip, Livermore, CA) for intranasal administration. Euthanasia, BALf recovery, and lung tissue preparation was performed as previously reported [10, 12] . BALf automated differentials were acquired by a HemaVet 950 Hematology Analyzer. 
Flow cytometry and cell sorting
ELISA, blocking, supplementation and Luminex
Cytokine levels were analyzed by standard sandwich ELISA performed as per manufacturer's instructions (BioLegend, San Diego, CA), modified to utilize europium-conjugated streptavidin (Perkin-Elmer), and detected with a Victor V3 plate reader (Perkin Elmer, San Jose, CA). Blocking experiments utilized antibodies to IFNγ (10μg/mL, BioLegend, San Diego, CA), IL-21 (10μg/mL, eBioscience, San Diego, CA), IL-22 (10μg/mL, eBioscience), CSF2 (10μg/mL, eBioscience), IL-9 (1μg/mL, eBioscience), IL-13 (2μg/mL, eBioscience), IL-4 (1μg/mL, eBioscience), IL-24 (2μg/mL, eBioscience), IL-3 (1μg/mL, eBioscience), Neuropilin-1 (1μg/ mL, R&D Systems, Minneapolis, MN), CD124 (1μg/mL, BD Biosciences, San Jose, CA), and corresponding isotype controls IgG1 and IgG2a (BioLegend, San Diego, CA). For CD124 blocking experiments, indicated cell types were incubated with 1μg/mL αCD124 at 4˚C for 15 minutes, washed twice with PBS, then combined into co-culture. Supplementation assays were performed with recombinant mouse IL-2 and IL-4 (R&D Systems, Minneapolis, MN) at the indicated concentrations. For Luminex assays, media from indicated cultured populations were snap frozen in liquid nitrogen and sent to Eve Technologies (Calgary, Ontario, Canada) for mouse 32-plex and TGFβ 3-plex analysis.
RNAseq and analysis
For RNA quantitation, CD4
Tem) cells were flow sorted as above, pelleted and snap frozen in liquid nitrogen. RNA extraction and RNAseq was performed at Ambry Genetics. Initial processing of the data was performed by using the trimmomatic [17] program to trim the poor quality reads, and fastQC to investigate read quality. TopHat [18] was used to align the reads to the "mm10" genome guided by the Gencode vm4 [19] annotations. To count the number of reads aligning to each feature in Gencode vm4, we used htseq-count [20] . RPKM values were calculated in R, and the differential expression analysis between "Hi" and "Lo" samples was performed using the negative binomial test implemented in DEseq2 [21] .
Histology and microscopy
Tissues were blocked, sectioned, and stained with H&E by the Case Western Reserve University Tissue Procurement and Histology Core Facility, and at AML Laboratories, Inc. (Jacksonville, FL). Unstained sections were stained with rat-anti-EpCAM-AF488 (eBioscience, San Diego, CA) or rat-anti-EpCAM-AF594 (BioLegend, San Diego, CA) at 6μg/mL, and rabbitanti-myeloperoxidase (1:100, Abcam, Cambridge, MA) then either anti-rabbit-APC (Thermo/ Fisher, Waltham, MA) or anti-rabbit-AF488 (Jackson ImmunoResearch, West Grove, PA) at 1:1000. Confocal analysis and imaging was performed on a Leica SP5 confocal microscope; H&E images were acquired with a Leica DM IL LED.
Clinical scoring
Scoring of H&E-stained lung tissues was performed by Dr. Cobb in a blinded fashion based on the rubric shown in Table 1 , with a maximum score of 9 characterized by severe airway epithelial hyperplasia and large numbers of infiltrating cells disseminated throughout the tissue.
Data analyses
All data are represented by mean ± SEM from at least 3 independent experiments, with the exception of the RNAseq, which was performed in duplicate for each subset. Pulmonary inflammation data sets include a minimum of four, but more commonly six animals per group per experiment. Data and statistical measurements were generated with GraphPad Prism -Tconv cells were isolated from WT mice using either magnetic beads (M) or sterile flow sorting (Fl), and stimulated with anti-CD3ε antibody alone or in co-culture for different amounts of time. Despite having not been previously exposed to PSA, we found that when cultured together, Tregs and Tconv cells synergistically produced IL-10 at 72 hours, while IFNγ production was simply additive (Fig 1A and 1B) . Moreover, variations of the ratio of Treg:Tconv demonstrates that the amount of IL-10 is proportional to the number of Tregs, not the number of Tconv cells (Fig 1C) . PSA exposure expands a CD4
Results
Rb
Lo T cell population in both humans [15] and mice [10, 11] , and this population was found to induce IL-10 production by lung-localized FoxP3 + Tregs [12] . We therefore isolated CD4 
Lo subset produced some IL-10 alone, the IL-10 concentration was increased over 2 fold in co-culture with FoxP3 + cells on day 3 (Fig 1D) . IFNγ trended down but was not significant while IL-2 was significantly reduced in co-culture (Fig 1D) . Importantly, the FoxP3-eGFP mice were isolated and stimulated as before in various combinations. Tem cells were the only subset to produce IL-10 alone, and the only ones to synergistically induce IL-10 in co-culture with Tregs (Fig 1E and 1F) (Fig 1E) or absence ( Fig  1F) of the IL-2Rα (CD25) on the Treg population (see S1 Fig for the gating strategy) (Fig 1G) . These findings align the identity of the cells capable of stimulating IL-10 production in Tregs with those which are selectively expanded by PSA [10] [11] [12] . More importantly, the data demonstrate that Rb
Lo
Tem cell communication with Tregs is independent of PSA, and is therefore an intrinsic property of this regulatory T cell subset.
IL-10 synergy is unique among common cytokines
Although IL-10 is necessary for Rb Lo Tem cell-mediated immune suppression [10, 12] , we performed multiplex Luminex analysis in order to identify other important cytokines and chemokines. We found that IL-10 was the only cytokine tested that displayed synergistic increases when Rb Lo Tem and FoxP3 + Tregs were in co-culture (Fig 2A) . Two other cytokines closely aligned with immune regulation, TGFβ1 and TGFβ2, were significantly down-regulated in coculture compared to the combined production of each cell population in isolation (Fig 2A) . All other cytokines and chemokines fell into two categories-reduced in co-culture (Fig 2B) or unchanged in co-culture (Fig 2C) . Notable molecules with robust decreases included IL-5, IL-6, IL-13, TNFα, and GM-CSF (Fig 2B) , while a notable unchanged molecule was IL-4 ( Fig 2C) . Tem cells eliminated the synergy (Fig 3B) , while Rb Lo Tem-conditioned media was able to robustly induce IL-10 production in live FoxP3 + Tregs (Fig 3C) . In addition, neutralizing antibody blockade of the Sema4-Neuropilin cell contact pathway reported to promote Treg activity [22] also did not reduce the synergistic production of IL-10 ( S3 Fig) . These data suggest that Rb Lo
IL-10 synergy depends on a soluble mediator
Tem cells communicate with Tregs via a soluble mediator(s).
To confirm that conditioned media from Rb Lo Tem cells also lead to IL-10 production in vivo, we induced pulmonary inflammation in IL-10-GFP reporter mice using lung house dust mite antigen (HDM) challenges and then intranasally administered conditioned media from either Rb Lo Tem or Rb Hi Tn cells, with untreated HDM mice and resting mice as controls. As seen in vitro (Fig 3C) , we found that Rb increased the percentage of IL-10-producing CD4 + T cells in the airway compared to untreated HDM-inflamed mice (Fig 3D and 3E ). Although resting mice had too few CD4 + T cells for robust analysis of their IL-10 expression pattern, there was no difference in the total number of CD4 + T cells in all HDM-challenged mice (Fig 3E) (Fig 4) . Neutralization of IL-4 eliminates IL-10 synergy. In order to identify the molecules mediating T cell synergy, we performed antibody neutralization experiments during co-culture of FoxP3 + Treg and Rb
Lo
Tem cells based on the transcriptomic data (Fig 4) . We found that neutralization of IL-4 eliminated the synergistic production of IL-10 ( Fig 5A) . In repeat experiments comparing neutralization of IL-4 to neutralization of IL-4Rα (CD124), which inhibits both type I and type II IL-4 receptor complexes, we found a corresponding elimination of IL-10 synergy (Fig 5B) . To identify which cell the IL-4 was impacting, we neutralized CD124 on only the Rb Tregs. We found no difference in IL-10 synergy (Fig 5C) . However, the inverse experiment in which the FoxP3 + Tregs were pre-blocked with anti-CD124 revealed robust inhibition of synergy ( Fig 5D) . Moreover, we tested the impact of IL-4 neutralization in FoxP3 + Treg monocultures using conditioned media from Rb Lo Tem cells. Once again, we found that blockade of IL-4 eliminated the IL-10 response (Fig 5E) .
In order to determine whether IL-4 was necessary and/or sufficient to induce IL-10 in Tregs, we cultured FoxP3 + Tregs with fresh media supplemented with recombinant IL-4 (rIL-4) and IL-2 (rIL-2) together and independently. Although our data already demonstrated that IL-2 was not the primary driver of IL-10 production (Fig 1D & 1F) , IL-2 was used because IL-2 concentrations robustly decrease in co-culture (Fig 1D) , suggesting that it may play the welldocumented pro-survival role for Tregs [23] . We found that rIL-4 induced IL-10 in mono-cultured FoxP3 + Tregs, but that the addition of IL-2 greatly enhanced this response despite the failure of IL-2 to robustly induce IL-10 in the absence of IL-4 ( Fig 5F) . This effect was dependent upon CD124, since neutralizing antibody completely reversed the impact of rIL-4 supplementation (Fig 5F) . Cytokine titration experiments with isolated FoxP3 + Tregs and varied concentrations of rIL-2 ( Fig 5G) and rIL-4 (Fig 5H) further demonstrated the dose-response nature of IL-10 production downstream of exposure to these cytokines. We also found that the expression of CD124 in FoxP3 + Tregs was dependent upon prior stimulation with αCD3ε
antibody, and this expression was not impacted by the presence of Rb Lo Tem cells (Fig 5I and  5J) . (Fig 6A) , overall clinical score ( Fig 6B; Table 1 ), neutrophils, lymphocytes, macrophages and eosinophils (Fig 6C) recovered in bronchoalveolar lavage fluid (BALf), was achieved with a single transfer of 60,000 WT cells. Moreover, tissue pathology measured by confocal microscopy for activated leukocytes ( Fig  6D) and hematoxylin and eosin staining (H&E; Fig 7) was returned to baseline in mice receiving WT Rb Lo Tem cells, while TriChrome and periodic acid-Schiff (PAS) staining revealed a reversal of collagen deposition (i.e. tissue remodeling) and mucus production, respectively (Fig 7) . Importantly, this potent ability to reverse lung inflammation was lost when the Rb 
Discussion
In this study, we discovered a novel pathway of immune suppression mediated by the Rb Tem cells on day 7 of acute HDM-induced asthma to test their ability to reverse inflammatory pathology. The total number of infiltrating cells (A), the clinical score (see Table 1 ) (B), normalized cellular differentials from BALf harvests (C), and tissue pathology (D) by immunofluorescence staining for EpCAM (green) and MPO (red) from representative sections of pulmonary tissue are shown. � = p<0.05; # = p>0.05. P value calculated from an unpaired Student's T-Test. Error bars show mean with SEM. n = 6 to 14 individual mice total per group, across two asthma trials, as indicated on the White Blood Cell counts in panel C.
IFNγ and other cytokines in vitro and pulmonary inflammation in vivo. We also discovered that this pathway is mediated by a combination of IL-2 and IL-4 secreted by Rb Lo Tem cells, leading to ligation of IL-4Rα (CD124) on αCD3ε-activated FoxP3 + Tregs and subsequent IL-10 production. The discovery of a novel T-effector cell-driven regulatory pathway and its underlying mechanism could have a major impact on how we understand the resolution of inflammation, the maintenance of homeostasis throughout the body, Treg behavior, and possibly how to control a variety of inflammatory diseases.
The interplay between T cell subsets to favor a particular response is not a novel concept. A recent example is the interaction between neuropilin-1 (Nrp1) and semaphorin-4a (Sema4a) [22] . Association of surface Sema4a on Tconv cells with Nrp1 on Tregs increased Treg survival and function in vitro and was found to be required for the in vivo suppression of inflammatory bowel disease. Here, we found that the direct cell-to-cell contact via the Sema4a-Nrp1 axis does not account for the suppressive influence of Rb Lo Tem cells on Tregs, as neutralization of Nrp1 with an antibody had no impact on in vitro IL-10 synergy. Instead, our data strongly support a contact-independent mechanism which relies upon soluble mediators, IL-2 and IL-4.
Since the establishment of the T H 1/T H 2 paradigm [24] [25] [26] , it has been widely recognized that T H 1 responses oppose T H 2 responses, and vice versa, and that this is driven by key T H 1 or T H 2-associated cytokines. IL-4 has long been characterized as a central inducer of T H 2 cell development [27] , a characteristic cytokine made by T H 2 cells [24] [25] [26] , and a critical factor leading to the suppression of T H 1 cell differentiation [27] [28] [29] . T H 2 responses were originally described as including IL-4, IL-5, IL-6, and IL-10 [24] [25] [26] . As sophistication in the laboratory setting increased, IL-6 and IL-10 were removed from this general list, but it is pertinent to recall that IL-4 has been well documented to induce IL-10 production in T cells [30] . In fact, IL-4 was linked to anti-inflammatory activity as far back as 1989 [31] . A more recent human trial demonstrated that subcutaneous injection of psoriatic lesions with human IL-4 significantly reduced clinical scores [32] , while IL-4 expression from a viral vector was able to prevent chondrocyte death and reduce cartilage erosion in a murine model of collagen-induced arthritis [33] . In EAE, gene delivery of IL-4 into mice selectively recruited FoxP3 + CD25 + Tregs which eliminated the disease pathology [34] . IL-4 has also been implicated in the regulatory mechanisms required for the anti-inflammatory effects of intravenous immunoglobulin [35] , and is known to be a robust driver of the wound healing phenotype of many macrophages, which includes IL-10 and TGFβ release [36, 37] . Indeed, IL-4 was previously shown to increase the suppressive capacity of CD25 + Tregs in vitro, although IL-10 was not assessed at the time [38] . Although it is unclear why IL-4 was not depleted in our experiments (Fig 2) like IL-2 (Fig  1) , it may be explained by differences in the relative rates of cytokine release by Rb Lo Tem cells and consumption by Tregs, these findings not only show that IL-4 is a highly pleiotropic cytokine with a robust history of immune suppression, but they also strongly support the notion that Rb Lo Tem cells could use IL-4 as a key driver of IL-10 and immune suppression under at least some inflammatory conditions.
In terms of asthma, the role of IL-4 is not entirely clear. In early descriptions of asthma one hundred years ago, asthma was divided into "intrinsic" or non-atopic and "extrinsic" atopic disease [39] . However, in the 1980s, the notion that asthma was nearly always atopic came into prominence [40] , which lead to the use of asthma as an exemplar T H 2-mediated atopic disease characterized by T H 2 cytokines like IL-4, IL-5 and IL-13, eosinophilia and increased IgE production [24] [25] [26] . More recent large-cohort studies, such as those conducted by the Severe Asthma Research Program (SARP), have reinvigorated the division of asthma into specific endotypes based on a variety of clinical characteristics. Of these endotypes, it is now widely recognized that atopic asthma is not the only endotype, and that non-atopic asthma accounts for up to 51% of all asthma cases in the US [41] .
Consistent with the interpretation that IL-4 is not a central driver of asthma, a number of clinical trials designed to selectively inhibit IL-4 in asthma patients have failed. The trials for a neutralizing anti-IL-4 antibody (Pasolizumab), a soluble IL-4 decoy receptor (Altrakincept), and even a mutant form of IL-4 with a proposed dominant negative impact on IL-4 function (Pitrakinra) all were halted due to a lack of meeting clinical benchmarks of efficacy. In contrast, efforts simultaneously targeting both IL-4 and IL-13 through IL-4Rα blockade have been more successful (Dupliumab), and primarily in eosinophilic asthma [42] . Since IL-13 uses the type II IL-4 receptor, which is comprised of IL-4Rα (CD124) and IL-13Rα (CD213a), the efficacy of Dupliumab supports the notion that IL-13 may be the more important cytokine in terms of asthma pathology. It is also becoming clear that the non-atopic neutrophilic endotypes are more likely driven by a Th17-dominated response, and these patients are much more likely to have greater disease severity and corticosteroid-resistance. Our results using a model of neutrophilic asthma (Fig 6A) fit with the well-known phenomenon that IL-4 opposes Th1 and Th17 responses, and induces IL-10 release in T cells [28, 29] .
In summary, our work has revealed a novel T cell-to-T cell regulatory pathway in which IL-2 and IL-4 from Rb 
